Rotavirus infection as cause of tacrolimus elevation in solid-organ-transplanted children

M Frühwirth1, H Fischer, B Simma

  • 1Department of Pediatrics, Department of Transplantation Surgery, School of Medicine, University of Innsbruck, Anichstrasse 356, A-6020 Innsbruck, Austria. Martin.Fruehwirth@uibk.ac.at

Insights

Rotavirus (RV) infection can increase tacrolimus (TAC) levels in organ transplant recipients. Early reduction of TAC dosage is recommended during acute gastroenteritis in these patients.

Area of Science:

  • Immunology
  • Virology
  • Pharmacology

Background:

  • Rotavirus (RV) is a leading cause of diarrheal illness in pediatric populations.
  • Solid-organ transplant (SOT) recipients require immunosuppressive therapy, such as tacrolimus (TAC), to prevent rejection.
  • Understanding drug-interactions in immunocompromised patients is crucial for effective management.

Observation:

  • Three SOT patients experienced elevated tacrolimus (TAC) trough levels during rotavirus (RV) infection.
  • RV was detected in feces for extended periods in these immunosuppressed patients compared to non-immunosuppressed infants.
  • The precise mechanisms driving TAC level increases during RV infection remain under investigation.

Findings:

  • Rotavirus infection is associated with significantly increased blood trough levels of tacrolimus in solid-organ transplant recipients.
  • Persistent fecal shedding of RV observed in transplant patients suggests altered viral kinetics under immunosuppression.
  • The study highlights a potential drug-virus interaction impacting tacrolimus pharmacokinetics.

Implications:

  • Close monitoring of tacrolimus (TAC) blood trough levels is essential in solid-organ transplant recipients presenting with acute gastroenteritis.
  • Prompt dosage reduction of TAC may be necessary to prevent toxicity during rotavirus infections.
  • Further research is warranted to elucidate the mechanisms behind rotavirus-induced alterations in tacrolimus metabolism or transport.